Science and Technology Science and Technology
Tue, November 22, 2011

Direction of Market Influences - Report Highlights BMC Software, Inc. and Pharmasset, Inc.


Published on 2011-11-22 06:08:10 - Market Wire
  Print publication without navigation


November 22, 2011 09:00 ET

Direction of Market Influences - Report Highlights BMC Software, Inc. and Pharmasset, Inc.

NEW YORK, NY--(Marketwire - Nov 22, 2011) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting BMC Software, Inc. (NASDAQ: [ BMC ]) and Pharmasset, Inc. (NASDAQ: [ VRUS ]). Gain market insight with full analysis and research downloads available at [ www.BrightonMarkets.com/index.php?coa=BMC&cob=VRUS ].

Upcoming macro-economic 'tides of influence' are buoyed by crisis both home and abroad. Spanish and Italian yields continue to climb as efforts by the European Central Bank have stopped short of establishing sovereign bond guarantees for any one country. The result is historic yields and a grave concern for the solvency of interbank lending. Markets were drawn to concerns over domestic policy stalemates producing downgrade risks. Despite the situation, there continues to be unique value and opportunity found within careful discretion.

Brighton Markets is releasing new coverage on BMC Software, Inc. for its current position within the technology industry. BMC Software, Inc. (BMC) is a software company. BMC provides information technology (IT) management solutions primarily for large enterprises. Its portfolio of IT management software solutions automates the management of IT processes, mainframe, distributed, virtualized and cloud computing environments, as well as applications and databases. The full research report on BMC Software, Inc. (NASDAQ: [ BMC ]) is available here: [ www.BrightonMarkets.com/index.php?coa=BMC ].

Brighton Markets has released research on Pharmasset, Inc. for its changing role within the healthcare industry. Pharmasset, Inc. is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel drugs to treat viral infections. The Company focuses on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection. The full research report on Pharmasset, Inc. (NASDAQ: [ VRUS ]) is available here: [ www.BrightonMarkets.com/index.php?cob=VRUS ].

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.


Contributing Sources